nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefepime—Extravasation—Carboplatin—bone cancer	0.0377	0.0377	CcSEcCtD
Cefepime—Haemolysis—Cisplatin—bone cancer	0.0304	0.0304	CcSEcCtD
Cefepime—Phlebitis—Carboplatin—bone cancer	0.0277	0.0277	CcSEcCtD
Cefepime—Neurotoxicity—Cisplatin—bone cancer	0.0249	0.0249	CcSEcCtD
Cefepime—Septicemia—Methotrexate—bone cancer	0.0233	0.0233	CcSEcCtD
Cefepime—Septicemia—Epirubicin—bone cancer	0.0218	0.0218	CcSEcCtD
Cefepime—Septicemia—Doxorubicin—bone cancer	0.0202	0.0202	CcSEcCtD
Cefepime—Nephropathy toxic—Cisplatin—bone cancer	0.0168	0.0168	CcSEcCtD
Cefepime—Injection site inflammation—Epirubicin—bone cancer	0.0149	0.0149	CcSEcCtD
Cefepime—Injection site inflammation—Doxorubicin—bone cancer	0.0137	0.0137	CcSEcCtD
Cefepime—Neurotoxicity—Methotrexate—bone cancer	0.0137	0.0137	CcSEcCtD
Cefepime—Neurotoxicity—Epirubicin—bone cancer	0.0128	0.0128	CcSEcCtD
Cefepime—Prothrombin level increased—Epirubicin—bone cancer	0.0121	0.0121	CcSEcCtD
Cefepime—Neurotoxicity—Doxorubicin—bone cancer	0.0118	0.0118	CcSEcCtD
Cefepime—Infection—Carboplatin—bone cancer	0.0117	0.0117	CcSEcCtD
Cefepime—Prothrombin level increased—Doxorubicin—bone cancer	0.0112	0.0112	CcSEcCtD
Cefepime—Extravasation—Cisplatin—bone cancer	0.0111	0.0111	CcSEcCtD
Cefepime—Pain—Carboplatin—bone cancer	0.01	0.01	CcSEcCtD
Cefepime—Vaginal moniliasis—Epirubicin—bone cancer	0.00983	0.00983	CcSEcCtD
Cefepime—Vulvovaginal candidiasis—Epirubicin—bone cancer	0.00943	0.00943	CcSEcCtD
Cefepime—Body temperature increased—Carboplatin—bone cancer	0.00928	0.00928	CcSEcCtD
Cefepime—Vaginal moniliasis—Doxorubicin—bone cancer	0.00909	0.00909	CcSEcCtD
Cefepime—Vulvovaginal mycotic infection—Epirubicin—bone cancer	0.00907	0.00907	CcSEcCtD
Cefepime—Local reaction—Epirubicin—bone cancer	0.00896	0.00896	CcSEcCtD
Cefepime—Vulvovaginal candidiasis—Doxorubicin—bone cancer	0.00873	0.00873	CcSEcCtD
Cefepime—Vulvovaginal mycotic infection—Doxorubicin—bone cancer	0.00839	0.00839	CcSEcCtD
Cefepime—Local reaction—Doxorubicin—bone cancer	0.00829	0.00829	CcSEcCtD
Cefepime—Encephalopathy—Methotrexate—bone cancer	0.00825	0.00825	CcSEcCtD
Cefepime—Phlebitis—Cisplatin—bone cancer	0.00814	0.00814	CcSEcCtD
Cefepime—Oral candidiasis—Epirubicin—bone cancer	0.00781	0.00781	CcSEcCtD
Cefepime—Liver disorder—Methotrexate—bone cancer	0.00777	0.00777	CcSEcCtD
Cefepime—Haemolytic anaemia—Cisplatin—bone cancer	0.00776	0.00776	CcSEcCtD
Cefepime—Oral candidiasis—Doxorubicin—bone cancer	0.00722	0.00722	CcSEcCtD
Cefepime—Hypercalcaemia—Epirubicin—bone cancer	0.00714	0.00714	CcSEcCtD
Cefepime—Stupor—Methotrexate—bone cancer	0.0071	0.0071	CcSEcCtD
Cefepime—Hypercalcaemia—Doxorubicin—bone cancer	0.0066	0.0066	CcSEcCtD
Cefepime—Extravasation—Methotrexate—bone cancer	0.00607	0.00607	CcSEcCtD
Cefepime—Pancytopenia—Cisplatin—bone cancer	0.00575	0.00575	CcSEcCtD
Cefepime—Extravasation—Epirubicin—bone cancer	0.00568	0.00568	CcSEcCtD
Cefepime—Vasodilation procedure—Epirubicin—bone cancer	0.00564	0.00564	CcSEcCtD
Cefepime—Vasodilation—Epirubicin—bone cancer	0.00564	0.00564	CcSEcCtD
Cefepime—Inflammation—Methotrexate—bone cancer	0.00546	0.00546	CcSEcCtD
Cefepime—Hypocalcaemia—Epirubicin—bone cancer	0.00542	0.00542	CcSEcCtD
Cefepime—Renal failure—Cisplatin—bone cancer	0.00531	0.00531	CcSEcCtD
Cefepime—Vaginal inflammation—Methotrexate—bone cancer	0.0053	0.0053	CcSEcCtD
Cefepime—Extravasation—Doxorubicin—bone cancer	0.00526	0.00526	CcSEcCtD
Cefepime—Vasodilation procedure—Doxorubicin—bone cancer	0.00522	0.00522	CcSEcCtD
Cefepime—Vasodilation—Doxorubicin—bone cancer	0.00522	0.00522	CcSEcCtD
Cefepime—Depressed level of consciousness—Methotrexate—bone cancer	0.00512	0.00512	CcSEcCtD
Cefepime—Inflammation—Epirubicin—bone cancer	0.00511	0.00511	CcSEcCtD
Cefepime—Hypocalcaemia—Doxorubicin—bone cancer	0.00501	0.00501	CcSEcCtD
Cefepime—Vaginal infection—Methotrexate—bone cancer	0.005	0.005	CcSEcCtD
Cefepime—Aplastic anaemia—Methotrexate—bone cancer	0.00497	0.00497	CcSEcCtD
Cefepime—Vaginal inflammation—Epirubicin—bone cancer	0.00496	0.00496	CcSEcCtD
Cefepime—Phosphatase alkaline increased—Epirubicin—bone cancer	0.00496	0.00496	CcSEcCtD
Cefepime—Coma—Methotrexate—bone cancer	0.00484	0.00484	CcSEcCtD
Cefepime—Colitis—Epirubicin—bone cancer	0.00476	0.00476	CcSEcCtD
Cefepime—Candida infection—Epirubicin—bone cancer	0.00473	0.00473	CcSEcCtD
Cefepime—Inflammation—Doxorubicin—bone cancer	0.00473	0.00473	CcSEcCtD
Cefepime—Vaginal infection—Epirubicin—bone cancer	0.00468	0.00468	CcSEcCtD
Cefepime—Aplastic anaemia—Epirubicin—bone cancer	0.00466	0.00466	CcSEcCtD
Cefepime—Sepsis—Methotrexate—bone cancer	0.0046	0.0046	CcSEcCtD
Cefepime—Phosphatase alkaline increased—Doxorubicin—bone cancer	0.00459	0.00459	CcSEcCtD
Cefepime—Vaginal inflammation—Doxorubicin—bone cancer	0.00459	0.00459	CcSEcCtD
Cefepime—Coma—Epirubicin—bone cancer	0.00453	0.00453	CcSEcCtD
Cefepime—Colitis—Doxorubicin—bone cancer	0.00441	0.00441	CcSEcCtD
Cefepime—Candida infection—Doxorubicin—bone cancer	0.00438	0.00438	CcSEcCtD
Cefepime—Vaginal infection—Doxorubicin—bone cancer	0.00433	0.00433	CcSEcCtD
Cefepime—Aplastic anaemia—Doxorubicin—bone cancer	0.00431	0.00431	CcSEcCtD
Cefepime—Sepsis—Epirubicin—bone cancer	0.0043	0.0043	CcSEcCtD
Cefepime—Hepatic failure—Methotrexate—bone cancer	0.00428	0.00428	CcSEcCtD
Cefepime—Erythema—Cisplatin—bone cancer	0.00422	0.00422	CcSEcCtD
Cefepime—Coma—Doxorubicin—bone cancer	0.00419	0.00419	CcSEcCtD
Cefepime—Phlebitis—Epirubicin—bone cancer	0.00418	0.00418	CcSEcCtD
Cefepime—Blood alkaline phosphatase increased—Epirubicin—bone cancer	0.00414	0.00414	CcSEcCtD
Cefepime—Hepatic function abnormal—Epirubicin—bone cancer	0.00412	0.00412	CcSEcCtD
Cefepime—Hepatic failure—Epirubicin—bone cancer	0.00401	0.00401	CcSEcCtD
Cefepime—Sepsis—Doxorubicin—bone cancer	0.00398	0.00398	CcSEcCtD
Cefepime—Anaemia—Cisplatin—bone cancer	0.0039	0.0039	CcSEcCtD
Cefepime—Phlebitis—Doxorubicin—bone cancer	0.00387	0.00387	CcSEcCtD
Cefepime—Blood alkaline phosphatase increased—Doxorubicin—bone cancer	0.00383	0.00383	CcSEcCtD
Cefepime—Hepatic function abnormal—Doxorubicin—bone cancer	0.00381	0.00381	CcSEcCtD
Cefepime—Renal impairment—Epirubicin—bone cancer	0.00378	0.00378	CcSEcCtD
Cefepime—Leukopenia—Cisplatin—bone cancer	0.00378	0.00378	CcSEcCtD
Cefepime—Hepatic failure—Doxorubicin—bone cancer	0.00371	0.00371	CcSEcCtD
Cefepime—Convulsion—Cisplatin—bone cancer	0.00366	0.00366	CcSEcCtD
Cefepime—Renal impairment—Doxorubicin—bone cancer	0.0035	0.0035	CcSEcCtD
Cefepime—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.00346	0.00346	CcSEcCtD
Cefepime—Anaphylactic shock—Cisplatin—bone cancer	0.00345	0.00345	CcSEcCtD
Cefepime—Infection—Cisplatin—bone cancer	0.00342	0.00342	CcSEcCtD
Cefepime—Thrombocytopenia—Cisplatin—bone cancer	0.00337	0.00337	CcSEcCtD
Cefepime—Eosinophilia—Methotrexate—bone cancer	0.00329	0.00329	CcSEcCtD
Cefepime—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.00324	0.00324	CcSEcCtD
Cefepime—Alanine aminotransferase increased—Epirubicin—bone cancer	0.00317	0.00317	CcSEcCtD
Cefepime—Pancytopenia—Methotrexate—bone cancer	0.00316	0.00316	CcSEcCtD
Cefepime—Neutropenia—Methotrexate—bone cancer	0.00311	0.00311	CcSEcCtD
Cefepime—Paraesthesia—Cisplatin—bone cancer	0.00309	0.00309	CcSEcCtD
Cefepime—Eosinophilia—Epirubicin—bone cancer	0.00308	0.00308	CcSEcCtD
Cefepime—Dyspnoea—Cisplatin—bone cancer	0.00307	0.00307	CcSEcCtD
Cefepime—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.003	0.003	CcSEcCtD
Cefepime—Bronchitis—Epirubicin—bone cancer	0.00299	0.00299	CcSEcCtD
Cefepime—Pneumonia—Methotrexate—bone cancer	0.00298	0.00298	CcSEcCtD
Cefepime—Gastrointestinal disorder—Cisplatin—bone cancer	0.00297	0.00297	CcSEcCtD
Cefepime—Pancytopenia—Epirubicin—bone cancer	0.00295	0.00295	CcSEcCtD
Cefepime—Pain—Cisplatin—bone cancer	0.00295	0.00295	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.00294	0.00294	CcSEcCtD
Cefepime—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.00294	0.00294	CcSEcCtD
Cefepime—Renal failure—Methotrexate—bone cancer	0.00291	0.00291	CcSEcCtD
Cefepime—Neutropenia—Epirubicin—bone cancer	0.00291	0.00291	CcSEcCtD
Cefepime—Eosinophilia—Doxorubicin—bone cancer	0.00285	0.00285	CcSEcCtD
Cefepime—Feeling abnormal—Cisplatin—bone cancer	0.00284	0.00284	CcSEcCtD
Cefepime—Pneumonia—Epirubicin—bone cancer	0.00279	0.00279	CcSEcCtD
Cefepime—Bronchitis—Doxorubicin—bone cancer	0.00277	0.00277	CcSEcCtD
Cefepime—Agranulocytosis—Methotrexate—bone cancer	0.00277	0.00277	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00275	0.00275	CcSEcCtD
Cefepime—Pancytopenia—Doxorubicin—bone cancer	0.00273	0.00273	CcSEcCtD
Cefepime—Renal failure—Epirubicin—bone cancer	0.00273	0.00273	CcSEcCtD
Cefepime—Body temperature increased—Cisplatin—bone cancer	0.00272	0.00272	CcSEcCtD
Cefepime—Urinary tract infection—Epirubicin—bone cancer	0.0027	0.0027	CcSEcCtD
Cefepime—Neutropenia—Doxorubicin—bone cancer	0.00269	0.00269	CcSEcCtD
Cefepime—Haemoglobin—Methotrexate—bone cancer	0.00267	0.00267	CcSEcCtD
Cefepime—Haemorrhage—Methotrexate—bone cancer	0.00266	0.00266	CcSEcCtD
Cefepime—Agranulocytosis—Epirubicin—bone cancer	0.00259	0.00259	CcSEcCtD
Cefepime—Pneumonia—Doxorubicin—bone cancer	0.00258	0.00258	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00254	0.00254	CcSEcCtD
Cefepime—Hypersensitivity—Cisplatin—bone cancer	0.00254	0.00254	CcSEcCtD
Cefepime—Renal failure—Doxorubicin—bone cancer	0.00252	0.00252	CcSEcCtD
Cefepime—Erythema multiforme—Methotrexate—bone cancer	0.00252	0.00252	CcSEcCtD
Cefepime—Haemoglobin—Epirubicin—bone cancer	0.0025	0.0025	CcSEcCtD
Cefepime—Urinary tract infection—Doxorubicin—bone cancer	0.00249	0.00249	CcSEcCtD
Cefepime—Haemorrhage—Epirubicin—bone cancer	0.00249	0.00249	CcSEcCtD
Cefepime—Agranulocytosis—Doxorubicin—bone cancer	0.0024	0.0024	CcSEcCtD
Cefepime—Chills—Methotrexate—bone cancer	0.00239	0.00239	CcSEcCtD
Cefepime—Diarrhoea—Cisplatin—bone cancer	0.00236	0.00236	CcSEcCtD
Cefepime—Erythema multiforme—Epirubicin—bone cancer	0.00235	0.00235	CcSEcCtD
Cefepime—Erythema—Methotrexate—bone cancer	0.00232	0.00232	CcSEcCtD
Cefepime—Haemoglobin—Doxorubicin—bone cancer	0.00232	0.00232	CcSEcCtD
Cefepime—Haemorrhage—Doxorubicin—bone cancer	0.0023	0.0023	CcSEcCtD
Cefepime—Dysgeusia—Methotrexate—bone cancer	0.00227	0.00227	CcSEcCtD
Cefepime—Chills—Epirubicin—bone cancer	0.00223	0.00223	CcSEcCtD
Cefepime—Vomiting—Cisplatin—bone cancer	0.00219	0.00219	CcSEcCtD
Cefepime—Erythema multiforme—Doxorubicin—bone cancer	0.00218	0.00218	CcSEcCtD
Cefepime—Rash—Cisplatin—bone cancer	0.00217	0.00217	CcSEcCtD
Cefepime—Dermatitis—Cisplatin—bone cancer	0.00217	0.00217	CcSEcCtD
Cefepime—Erythema—Epirubicin—bone cancer	0.00217	0.00217	CcSEcCtD
Cefepime—Anaemia—Methotrexate—bone cancer	0.00214	0.00214	CcSEcCtD
Cefepime—Dysgeusia—Epirubicin—bone cancer	0.00212	0.00212	CcSEcCtD
Cefepime—Leukopenia—Methotrexate—bone cancer	0.00207	0.00207	CcSEcCtD
Cefepime—Chills—Doxorubicin—bone cancer	0.00207	0.00207	CcSEcCtD
Cefepime—Nausea—Cisplatin—bone cancer	0.00205	0.00205	CcSEcCtD
Cefepime—Convulsion—Methotrexate—bone cancer	0.00201	0.00201	CcSEcCtD
Cefepime—Erythema—Doxorubicin—bone cancer	0.00201	0.00201	CcSEcCtD
Cefepime—Anaemia—Epirubicin—bone cancer	0.002	0.002	CcSEcCtD
Cefepime—Agitation—Epirubicin—bone cancer	0.00199	0.00199	CcSEcCtD
Cefepime—Dysgeusia—Doxorubicin—bone cancer	0.00196	0.00196	CcSEcCtD
Cefepime—Leukopenia—Epirubicin—bone cancer	0.00194	0.00194	CcSEcCtD
Cefepime—Confusional state—Methotrexate—bone cancer	0.00191	0.00191	CcSEcCtD
Cefepime—Anaphylactic shock—Methotrexate—bone cancer	0.00189	0.00189	CcSEcCtD
Cefepime—Convulsion—Epirubicin—bone cancer	0.00188	0.00188	CcSEcCtD
Cefepime—Infection—Methotrexate—bone cancer	0.00188	0.00188	CcSEcCtD
Cefepime—Anaemia—Doxorubicin—bone cancer	0.00185	0.00185	CcSEcCtD
Cefepime—Thrombocytopenia—Methotrexate—bone cancer	0.00185	0.00185	CcSEcCtD
Cefepime—Agitation—Doxorubicin—bone cancer	0.00184	0.00184	CcSEcCtD
Cefepime—Leukopenia—Doxorubicin—bone cancer	0.0018	0.0018	CcSEcCtD
Cefepime—Confusional state—Epirubicin—bone cancer	0.00178	0.00178	CcSEcCtD
Cefepime—Anaphylactic shock—Epirubicin—bone cancer	0.00177	0.00177	CcSEcCtD
Cefepime—Infection—Epirubicin—bone cancer	0.00176	0.00176	CcSEcCtD
Cefepime—Shock—Epirubicin—bone cancer	0.00174	0.00174	CcSEcCtD
Cefepime—Convulsion—Doxorubicin—bone cancer	0.00174	0.00174	CcSEcCtD
Cefepime—Thrombocytopenia—Epirubicin—bone cancer	0.00173	0.00173	CcSEcCtD
Cefepime—Paraesthesia—Methotrexate—bone cancer	0.0017	0.0017	CcSEcCtD
Cefepime—Dyspnoea—Methotrexate—bone cancer	0.00169	0.00169	CcSEcCtD
Cefepime—Confusional state—Doxorubicin—bone cancer	0.00165	0.00165	CcSEcCtD
Cefepime—Anaphylactic shock—Doxorubicin—bone cancer	0.00164	0.00164	CcSEcCtD
Cefepime—Gastrointestinal disorder—Methotrexate—bone cancer	0.00163	0.00163	CcSEcCtD
Cefepime—Infection—Doxorubicin—bone cancer	0.00163	0.00163	CcSEcCtD
Cefepime—Pain—Methotrexate—bone cancer	0.00162	0.00162	CcSEcCtD
Cefepime—Shock—Doxorubicin—bone cancer	0.00161	0.00161	CcSEcCtD
Cefepime—Thrombocytopenia—Doxorubicin—bone cancer	0.0016	0.0016	CcSEcCtD
Cefepime—Paraesthesia—Epirubicin—bone cancer	0.00159	0.00159	CcSEcCtD
Cefepime—Dyspnoea—Epirubicin—bone cancer	0.00158	0.00158	CcSEcCtD
Cefepime—Feeling abnormal—Methotrexate—bone cancer	0.00156	0.00156	CcSEcCtD
Cefepime—Gastrointestinal pain—Methotrexate—bone cancer	0.00155	0.00155	CcSEcCtD
Cefepime—Gastrointestinal disorder—Epirubicin—bone cancer	0.00153	0.00153	CcSEcCtD
Cefepime—Constipation—Epirubicin—bone cancer	0.00151	0.00151	CcSEcCtD
Cefepime—Pain—Epirubicin—bone cancer	0.00151	0.00151	CcSEcCtD
Cefepime—Urticaria—Methotrexate—bone cancer	0.0015	0.0015	CcSEcCtD
Cefepime—Body temperature increased—Methotrexate—bone cancer	0.00149	0.00149	CcSEcCtD
Cefepime—Abdominal pain—Methotrexate—bone cancer	0.00149	0.00149	CcSEcCtD
Cefepime—Paraesthesia—Doxorubicin—bone cancer	0.00147	0.00147	CcSEcCtD
Cefepime—Dyspnoea—Doxorubicin—bone cancer	0.00146	0.00146	CcSEcCtD
Cefepime—Feeling abnormal—Epirubicin—bone cancer	0.00146	0.00146	CcSEcCtD
Cefepime—Gastrointestinal pain—Epirubicin—bone cancer	0.00145	0.00145	CcSEcCtD
Cefepime—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00141	0.00141	CcSEcCtD
Cefepime—Urticaria—Epirubicin—bone cancer	0.00141	0.00141	CcSEcCtD
Cefepime—Pain—Doxorubicin—bone cancer	0.0014	0.0014	CcSEcCtD
Cefepime—Constipation—Doxorubicin—bone cancer	0.0014	0.0014	CcSEcCtD
Cefepime—Body temperature increased—Epirubicin—bone cancer	0.0014	0.0014	CcSEcCtD
Cefepime—Abdominal pain—Epirubicin—bone cancer	0.0014	0.0014	CcSEcCtD
Cefepime—Hypersensitivity—Methotrexate—bone cancer	0.00139	0.00139	CcSEcCtD
Cefepime—Feeling abnormal—Doxorubicin—bone cancer	0.00135	0.00135	CcSEcCtD
Cefepime—Gastrointestinal pain—Doxorubicin—bone cancer	0.00134	0.00134	CcSEcCtD
Cefepime—Pruritus—Methotrexate—bone cancer	0.00134	0.00134	CcSEcCtD
Cefepime—Hypersensitivity—Epirubicin—bone cancer	0.0013	0.0013	CcSEcCtD
Cefepime—Urticaria—Doxorubicin—bone cancer	0.0013	0.0013	CcSEcCtD
Cefepime—Abdominal pain—Doxorubicin—bone cancer	0.00129	0.00129	CcSEcCtD
Cefepime—Body temperature increased—Doxorubicin—bone cancer	0.00129	0.00129	CcSEcCtD
Cefepime—Diarrhoea—Methotrexate—bone cancer	0.00129	0.00129	CcSEcCtD
Cefepime—Pruritus—Epirubicin—bone cancer	0.00125	0.00125	CcSEcCtD
Cefepime—Dizziness—Methotrexate—bone cancer	0.00125	0.00125	CcSEcCtD
Cefepime—Diarrhoea—Epirubicin—bone cancer	0.00121	0.00121	CcSEcCtD
Cefepime—Hypersensitivity—Doxorubicin—bone cancer	0.00121	0.00121	CcSEcCtD
Cefepime—Vomiting—Methotrexate—bone cancer	0.0012	0.0012	CcSEcCtD
Cefepime—Rash—Methotrexate—bone cancer	0.00119	0.00119	CcSEcCtD
Cefepime—Dermatitis—Methotrexate—bone cancer	0.00119	0.00119	CcSEcCtD
Cefepime—Headache—Methotrexate—bone cancer	0.00118	0.00118	CcSEcCtD
Cefepime—Dizziness—Epirubicin—bone cancer	0.00117	0.00117	CcSEcCtD
Cefepime—Pruritus—Doxorubicin—bone cancer	0.00116	0.00116	CcSEcCtD
Cefepime—Vomiting—Epirubicin—bone cancer	0.00112	0.00112	CcSEcCtD
Cefepime—Nausea—Methotrexate—bone cancer	0.00112	0.00112	CcSEcCtD
Cefepime—Diarrhoea—Doxorubicin—bone cancer	0.00112	0.00112	CcSEcCtD
Cefepime—Rash—Epirubicin—bone cancer	0.00112	0.00112	CcSEcCtD
Cefepime—Dermatitis—Epirubicin—bone cancer	0.00111	0.00111	CcSEcCtD
Cefepime—Headache—Epirubicin—bone cancer	0.00111	0.00111	CcSEcCtD
Cefepime—Dizziness—Doxorubicin—bone cancer	0.00108	0.00108	CcSEcCtD
Cefepime—Nausea—Epirubicin—bone cancer	0.00105	0.00105	CcSEcCtD
Cefepime—Vomiting—Doxorubicin—bone cancer	0.00104	0.00104	CcSEcCtD
Cefepime—Rash—Doxorubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Cefepime—Dermatitis—Doxorubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Cefepime—Headache—Doxorubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Cefepime—Nausea—Doxorubicin—bone cancer	0.000972	0.000972	CcSEcCtD
